Intratumoral FOXP3+VEGFR2+ regulatory T cells are predictive markers for recurrence and survival in patients with colorectal cancer

Clinical Immunology

Volumn 146, Issue 1, 2013, Pages 26-33

  Suzuki, Hiroyuki ^a   Onishi, Hideya ^a   Morisaki, Takashi ^b   Tanaka, Masao ^c   Katano, Mitsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Fukuoka General Cancer Clinic   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Disease free survival; Overall survival; Regulatory t cells; Vascular endothelial growth factor receptor2; VEGFR2

Indexed keywords

TRANSCRIPTION FACTOR FOXP3; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CD8+ T LYMPHOCYTE; COLORECTAL CANCER; CORRELATION ANALYSIS; FEMALE; FLUORESCENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

AGED; COLORECTAL NEOPLASMS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL ANALYSIS; T-LYMPHOCYTES, REGULATORY; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84870375752     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2012.10.007     Document Type: Article

References (22)

1. Whiteside T.L. The tumor microenvironment and its role in promoting tumor growth. Oncogene 2008, 27:5904-5912.
2. Peggs K.S., Quezada S.A., Allison J.P. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy. Immunol. Rev. 2008, 224:141-165.
3. + suppressive T cells in colorectal cancer tissue. Gut 2009, 58:520-529.
4. Pages F., Berger A., Camus M., Sanchez-Cabo F., Costes A., Molidor R., et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N. Engl. J. Med. 2005, 353:2654-2666.
5. Maloy K., Powrie F. Regulatory T-cells in the control of immune pathology. Nat. Immunol. 2001, 2:816-822.
6. Fu J., Xu D., Liu Z., Shi M., Zhao P., Fu B., et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 2007, 132:2328-2339.
7. Gao Q., Qiu S.J., Fan J., Zhou J., Wang X.Y., Xiao Y.S., et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J. Clin. Oncol. 2007, 25:2586-2593.
8. +/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:18538-18543.
9. + cell ratio is a predictive marker for survival in patients with colorectal cancer. Cancer Immunol. Immunother. 2010, 59:653-661.
10. Ohm J.E., Carbone D.P. VEGF as a mediator of tumor-associated immunodeficiency. Immunol. Res. 2001, 23:263-272.
11. + Treg. Eur. J. Immunol. 2010, 40:197-203.
12. Ling K.L., Pratap S.E., Bates G.J., Singh B., Mortensen N.J., George B.D., et al. Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients. Cancer Immun. 2007, 7:7.
13. + regulatory T cells in human colorectal cancer. J. Transl. Med. 2006, 4:52.
14. Domingues I., Rino J., Demmers J.A., de Lanerolle P., Santos S.C. VEGFR2 translocates to the nucleus to regulate its own transcription. PLoS One 2011, 6:e25668.
15. Curiel T.J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 2004, 10:942-949.
16. Wolf D., Wolf A.M., Rumpold H., Fiegl H., Zeimet A.G., Muller-Holzner E., et al. The expression of the regulatory T cell-specific fork-head box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin. Cancer Res. 2005, 11:8326-8331.
17. + regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin. Cancer Res. 2006, 12:5423-5434.
18. Bates G.J., Fox S.B., Han C., Leek R.D., Garcia J.F., Harris A.L., et al. Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J. Clin. Oncol. 2006, 24:5373-5380.
19. + regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 2003, 98:1089-1099.
20. Liyanage U.K., Moore T.T., Joo H.G., Tanaka Y., Herrmann V., Doherty G., et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J. Immunol. 2002, 169:2756-2761.
21. + regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Haematologica 2008, 93:193-200.
22. Ponz de Leon M., Sant M., Micheli A., Sacchetti C., Di Gregorio C., Fante R., et al. Clinical and pathologic prognostic indicators in colorectal cancer. A population-based study. Cancer 1992, 69:626-635.